Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
3 key takeaways from a survey of cardiologists, health leaders & CVD patients | Sotagliflozin & heart failure
Wednesday, February 22, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

The evolution of care: 3 key takeaways from a new survey of cardiologists, health leaders and CVD patients

The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment. 

READ MORE >
older male patient and doctor
Share on Twitter Share on Facebook Share on Linkedin

The evolution of care: 3 key takeaways from a new survey of cardiologists, health leaders and CVD patients

Share on Twitter Share on Facebook Share on Linkedin
older male patient and doctor
The report, developed by Abbott, examined everything from AI to social determinants of health. One key finding was that patients grade their overall satisfaction with a physician or hospital based on much more than the effectiveness of their treatment. 
READ MORE >

Increased AFib screening improves bradyarrhythmia detection—but is it a mixed blessing?

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value? 

READ MORE >
The increased use of implantable loop recorders (ILRs) is associated with identifying more bradyarrhythmias such as bradycardia, according to new findings published in JAMA Cardiology.
Share on Twitter Share on Facebook Share on Linkedin

Increased AFib screening improves bradyarrhythmia detection—but is it a mixed blessing?

Share on Twitter Share on Facebook Share on Linkedin
The increased use of implantable loop recorders (ILRs) is associated with identifying more bradyarrhythmias such as bradycardia, according to new findings published in JAMA Cardiology.
When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value? 
READ MORE >

What clinical research tells us about sotagliflozin and heart failure

Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.

READ MORE >
Bertram Pitt, MD, a professor of medicine emeritus at the University of Michigan School of Medicine, explains the role of sodium–glucose co-transporter-2 (SGLT-2) inhibitors for heart failure (HF). Initially developed to treat diabetes, these drugs have been shown to improve HF outcomes in HF in several large, randomized trials over the past few years, including SOLOIST-WHF, DAPA-HF, EMPEROR-Preserved, and the DELIVER trials. The positive results earned their inclusion in the 2022 AHA/ACC/HFSA Guideline for
Share on Twitter Share on Facebook Share on Linkedin

What clinical research tells us about sotagliflozin and heart failure

Share on Twitter Share on Facebook Share on Linkedin
Bertram Pitt, MD, a professor of medicine emeritus at the University of Michigan School of Medicine, explains the role of sodium–glucose co-transporter-2 (SGLT-2) inhibitors for heart failure (HF). Initially developed to treat diabetes, these drugs have been shown to improve HF outcomes in HF in several large, randomized trials over the past few years, including SOLOIST-WHF, DAPA-HF, EMPEROR-Preserved, and the DELIVER trials. The positive results earned their inclusion in the 2022 AHA/ACC/HFSA Guideline for
Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.
READ MORE >

Featured Articles

ChatGPT and cardiology: A close look at the strengths and weaknesses of AI chatbots

Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. 

READ MORE >
A team of cardiologists from Cleveland Clinic and Stanford University recently tested ChatGPT, the popular artificial intelligence (AI) model, to see if it could accurately answer questions about preventive cardiology and cardiovascular disease. The model performed well, only missing a handful of questions, and the researchers concluded that ChatGPT showed considerable potential. Cleveland Clinic cardiologist Ashish Sarraju, MD, was the lead author of that study. #ChartGPT
Share on Twitter Share on Facebook Share on Linkedin

ChatGPT and cardiology: A close look at the strengths and weaknesses of AI chatbots

Share on Twitter Share on Facebook Share on Linkedin
A team of cardiologists from Cleveland Clinic and Stanford University recently tested ChatGPT, the popular artificial intelligence (AI) model, to see if it could accurately answer questions about preventive cardiology and cardiovascular disease. The model performed well, only missing a handful of questions, and the researchers concluded that ChatGPT showed considerable potential. Cleveland Clinic cardiologist Ashish Sarraju, MD, was the lead author of that study. #ChartGPT
Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. 
READ MORE >

Medtronic’s new extravascular ICD gains key approval

Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 

READ MORE >
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new extravascular ICD gains key approval

Share on Twitter Share on Facebook Share on Linkedin
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 
READ MORE >

In Case You Missed It

Researchers design new material for wearable devices: ‘You cannot feel it, and you will likely forget about it’

The soft, stretchable material creates so little pressure that users will likely not even even be able to feel it. 

READ MORE >
Image courtesy of the University of Missouri Zheng Yan, PhD. He led a team of engineers at the University of Missouri (UM) to develop a new soft, stretchable material that could potentially be used in wearable devices that gather key cardiovascular data. The group shared its findings in Science Advances, noting that the material creates such a small amount of pressure that users will not even notice they have it on.
Share on Twitter Share on Facebook Share on Linkedin

Researchers design new material for wearable devices: ‘You cannot feel it, and you will likely forget about it’

Share on Twitter Share on Facebook Share on Linkedin
Image courtesy of the University of Missouri Zheng Yan, PhD. He led a team of engineers at the University of Missouri (UM) to develop a new soft, stretchable material that could potentially be used in wearable devices that gather key cardiovascular data. The group shared its findings in Science Advances, noting that the material creates such a small amount of pressure that users will not even notice they have it on.
The soft, stretchable material creates so little pressure that users will likely not even even be able to feel it. 
READ MORE >

New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more

The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a "critical roadmap" for clinicians. 

READ MORE >
Tablet projecting metaphorical medical hologram
Share on Twitter Share on Facebook Share on Linkedin

New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more

Share on Twitter Share on Facebook Share on Linkedin
Tablet projecting metaphorical medical hologram
The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a "critical roadmap" for clinicians. 
READ MORE >

In Other News

Marburg virus outbreak in Equatorial Guinea raises public health concerns

An outbreak of Marburg virus disease has been confirmed in Equatorial Guinea for the first time, the World Health Organization (WHO) reported.

READ MORE >
Virus Outbreak
Share on Twitter Share on Facebook Share on Linkedin

Marburg virus outbreak in Equatorial Guinea raises public health concerns

Share on Twitter Share on Facebook Share on Linkedin
Virus Outbreak
An outbreak of Marburg virus disease has been confirmed in Equatorial Guinea for the first time, the World Health Organization (WHO) reported.
READ MORE >

Watch for prestigious medical schools trying to tip the scales in their favor during Match Day 2023

Who benefits and who pays the price when top-ranked medical schools withhold comparative student data from radiology residency program directors? Radiology researchers at Duke recently documented the commonness of the problematic practice.

READ MORE >
Charles Maxfield, MD, professor of radiology and pediatrics, Duke pediatric radiology, vice chair of education, and division chief of pediatric radiology, discusses residency Match Day 2023 and how prestigious medical schools to try tipping the scales in their collective favor for the best students. #Matchday 2023
Share on Twitter Share on Facebook Share on Linkedin

Watch for prestigious medical schools trying to tip the scales in their favor during Match Day 2023

Share on Twitter Share on Facebook Share on Linkedin
Charles Maxfield, MD, professor of radiology and pediatrics, Duke pediatric radiology, vice chair of education, and division chief of pediatric radiology, discusses residency Match Day 2023 and how prestigious medical schools to try tipping the scales in their collective favor for the best students. #Matchday 2023
Who benefits and who pays the price when top-ranked medical schools withhold comparative student data from radiology residency program directors? Radiology researchers at Duke recently documented the commonness of the problematic practice.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme